載入中
Scribe Therapeutics is a clinical-stage biotechnology company focused on developing in vivo CRISPR-based genetic medicines. The company engineers proprietary technologies to target the genetic drivers of disease, with an initial focus on atherosclerotic cardiovascular disease (ASCVD), aiming to shift treatment from chronic care to preventative intervention.
前收盤價
US$21.17
+US$1.94 · +10.09%
盤中時間採用ET。市場資料可能有所延遲。
Scribe Therapeutics is a clinical-stage biotechnology company focused on developing in vivo CRISPR-based genetic medicines. The company engineers proprietary technologies to target the genetic drivers of disease, with an initial focus on atherosclerotic cardiovascular disease (ASCVD), aiming to shift treatment from chronic care to preventative intervention.
日內區間
目前US$21.17
52週區間
目前US$21.17
盤中時間採用ET。市場資料可能有所延遲。
Scribe Therapeutics is a clinical-stage biotechnology company focused on developing in vivo CRISPR-based genetic medicines. The company engineers proprietary technologies to target the genetic drivers of disease, with an initial focus on atherosclerotic cardiovascular disease (ASCVD), aiming to shift treatment from chronic care to preventative intervention.
日內區間
目前US$21.17
52週區間
目前US$21.17
第三方分析師預期可能變動，並非 GoAI 建議。
平均目標
US$51.75
上漲空間 144.45%報告持有此股票曝險的交易所交易基金。
ARK Genomic Revolution ETFARKG1586.3萬0.77%15.57億 USD0.75%US$51.30+4.08%
iShares Russell 2000 ETFIWM494.97萬0.01%787.4億 USD0.19%US$278.94+0.49%
iShares Russell 2000 Growth ETFIWO100.45萬0.01%139.17億 USD0.24%US$356.78+0.94%
iShares Micro-Cap ETFIWC58.3萬0.04%13.17億 USD0.60%US$183+0.11%
Vanguard Morningstar Total Stock Market ETFVTI47.22萬0.00%2.3兆 USD0.03%US$381.94+0.63%
Vanguard Extended Market ETFVXF17.57萬0.00%954億 USD0.05%US$235+0.80%
iShares Russell 2500 ETFSMMD10.42萬0.00%40.62億 USD0.23%US$86.29+0.38%
Global X - Russell 2000 ETFRSSL9.75萬0.01%14.19億 USD0.08%US$109.09+0.21%ARK Genomic Revolution ETFARKGiShares Russell 2000 ETFIWMiShares Russell 2000 Growth ETFIWOiShares Micro-Cap ETFIWCVanguard Morningstar Total Stock Market ETFVTIVanguard Extended Market ETFVXFiShares Russell 2500 ETFSMMDGlobal X - Russell 2000 ETFRSSLAI 生成內容及延遲市場資料僅供資訊與教育用途，不構成投資建議。
